Supplemental Figure 1 from Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 1: Distribution of tumor mutation burden (TMB) across different tumor types, comparing TMB in this HCC cohort (N=127) to the most common other tumor types in the MSK-IMPACT clinical sequencing cohort. The mutation rate was plotted as in (Zehir et al. Nat Med 2017).47
Authors: James J. Harding, Subhiksha Nandakumar, Joshua Armenia, Danny N. Khalil, Melanie Albano, Michele Ly, Jinru Shia, Jaclyn F. Hechtman, Ritika Kundra, Imane El Dika, Richard K. Do, Yichao Sun, T. Peter Kingham, Michael I. D'Angelica, Michael F. Berger, David M. Hyman, William Jarnagin, David S. Klimstra, Yelena Y. Janjigian, David B. Solit, Nikolaus Schultz, Ghassan K. Abou-Alfa
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362407917